Sign Out
Rhinitis sicca, hypersensitivity to the active ingredient or to any of the excipients.
Risk-to-benefit ratio must be weighed for use in the following cases: Patients treated with MAO-inhibitors and other drugs potentially increasing blood pressure, increased intraocular pressure (esp. narrow-angle glaucoma), severe CV disease (e.g. coronary heart disease, hypertension), phaeochromocytoma, metabolic disorders (e.g. hyperthyroidism, diabetes mellitus, porphyria, hyperplasia of the prostate).
Contains benzalkonium chloride as preservative, must not be used in known hypersensitivity to this substance.
